Patent Assignment
Reel/Frame 059553/0377
Assignment of Assignor's Interest
Recorded: 2022-04-11
Pages: 9
Assignors
RUBENSTEIN, DAVID SCOTT
Executed: 2021-10-06
DERMAVANT SCIENCES, INC. (F/K/A ROIVANT DERMATOLOGY, INC.)
Executed: 2022-02-17
Assignee
DERMAVANT SCIENCES GMBH
VIADUKTSTRASSE 8, BASEL, 4051, SWITZERLAND
Covered Property
(1)
Remittive Effects of Tapinarof in the Treatment of Plaque Psoriasis, Atopic Dermatitis, or Radiation Dermatitis
Application:
63/260,322 →
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 11, 2022
From: MCHALE, KIMBERLY ANN; DERMAVANT SCIENCES, INC. (F/K/A ROIVANT DERMATOLOGY, INC.)
To: DERMAVANT SCIENCES GMBH
Reel/Frame 059553/0406 →
First Supplement to Patent Security Agreement Recorded on May 17, 2021 at Reel/Frame 056261/0437
Nov 9, 2022
From: DERMAVENT SCIENCES GMBH
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 061904/0811 →
First Supplement to Patent Security Agreement Recorded on May 19, 2021 at Reel/Frame 056399/0778
Nov 9, 2022
From: DERMAVENT SCIENCES GMBH
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 061904/0964 →
Release of Security Interest
Oct 29, 2024
From: US BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: DERMAVENT SCIENCES GMBH
Reel/Frame 069274/0101 →